Wells Fargo Maintains Overweight on Tenet Healthcare, Lowers Price Target to $71
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Stephen Baxter has maintained an Overweight rating on Tenet Healthcare (NYSE:THC) but lowered the price target from $83 to $71.
October 20, 2023 | 2:50 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Wells Fargo has maintained an Overweight rating on Tenet Healthcare but lowered the price target from $83 to $71.
The news is directly related to Tenet Healthcare. While the Overweight rating indicates a positive outlook, the reduction in price target might lead to mixed reactions in the market. Therefore, the short-term impact on the stock price is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100